The 22nd MedTech Investing Europe Conference, held on 26-27 April 2016 in Lausanne Switzerland welcomed over 150 attendees, showcased over 40 presenting companies and delivered a conference programme filled with the biggest investors and life science specialists.
Every MTI event brings together some of the most pro-active and ambitious investors with the most ground-breaking early- to mid-stage life science companies from around the world looking for their next round of investment.
Our investor community includes family offices and private wealth holders, VC’s, major corporations, angel investors and many more, all hungry for their next life science investment deal and eager to network and meet with their fellow investor professionals.
MTI speakers represent some of the most successful investors, entrepreneurs and life science specialists in the sector. Chosen for their knowledge, insight and first-hand experience they will give our audience the tools they need to develop winning investment strategies, successful commercialisation plans and accurately plan for the future.
To enquire about speaking opportunities at September’s London event, please contact Peter Newton, email@example.com or +44(0)203 763 2800.
Over the last 22 events we have showcased over 800 early- to mid-stage life science companies to our unrivalled audience of investors. Representing all areas of life sciences our presenting companies originate from over 30 countries and are at a range of different stages from pre-clinical to commercialisation. Just some of the previous companies include:
The MTI conference programmes address the biggest topics in the industry today, from investment topics such as “Where is the money coming from?” and “What do family offices look for and how do they invest?” to wider challenges such as “How to access global markets” and “Understanding the full impact of government policy and regulation”. The conference programmes are developed in conjunction with the MTI Investor Advisory Board – a collection of the biggest investors in the sector with assets under management of over $28bn.
How healthy is the life sciences industry today? What should be on the radar for investors and entrepreneurs? With Medtech increasingly converging with digital healthcare, will innovation fuel investment or will tougher regulatory environments and increased competition for funding slow growth in the sector?
Innovation and collaboration are the life blood of the Medtech sector. But with constantly changing cycles and sources of investment, a clear understanding of investor objectives and strategies is essential. So where is investment coming from? What do different investors want to see and when do they want to invest?
Digital healthcare and big data analysis is an ever-growing market, but one that raises questions over regulatory affairs, IP, data privacy and cyber-security. With telecommunication and electronics companies making waves in the market, choosing partners wisely is key. But how will rapid change effect the sector and how can investors and entrepreneurs keep pace?
Special pre-scheduled individual One-To-One meetings will be taking place in our dedicated meeting area. This session will consist of 4 x 20min One to One meetings.
Sponsors of the MTI events represent the companies and organisations providing services to the venture-stage life science industry. To enquire about sponsorship opportunities at upcoming MTI events, please contact Peter Newton, firstname.lastname@example.org or +44(0)203 763 2800.
We are proud to be working with the following sponsors for the 23rd MedTech Investing Europe Conference, 20-21 September 2016 in London, UK:
Campden Wealth 30 Cannon Street London EC4M 6XH, United Kingdom